(2013) evaluated the gene expression of SOCS3, a well-defined STAT3 inhibitor and therefore affects Th17 skewing (52), in bronchial mucosa from COPD patients (53). This evidence concerns the gene STAT3 and chronic obstructive pulmonary disease.